Trial Profile
DS-7113b phase III study A randomized double-blind comparison study with immediate release (IR) oxycodone in opioid-naive patients with cancer pain
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Jun 2016
Price :
$35
*
At a glance
- Drugs Hydromorphone (Primary) ; Oxycodone
- Indications Cancer pain
- Focus Therapeutic Use
- Sponsors Daiichi Sankyo Company
- 17 Jun 2016 New trial record